Course summary

This MSc will provide you with up-to-date knowledge of advances in the field, research experience with internationally renowned research groups and transferable skills to give you a springboard for your future career. Course description Course Directors: Professor Mimoun Azzouz, Professor Janine Kirby This innovative and progressive course combines the research strengths of our Faculty of Medicine, Dentistry and Health, academic and industry partners, and leading international scientists. You’ll study genetic factors associated with rare inherited diseases and how gene and cell therapies can be adopted as treatment options, as well as the principles of gene and cell therapies. You'll also explore the development of specific and efficient medical treatments tailored to individual patients. On our MSc, you'll develop essential skills for each step of the translational pathway of cell and gene therapy products, including: discovery, vector design, GLP pre-clinical regulatory studies, GMP manufacturing and analytics, process innovation, quality control, qualified person (QP), safety, clinical design, commercialisation and market authorisation. The course will provide you with up-to-date knowledge of advances in the field, offering a comprehensive road map on the required steps to take an advanced therapy project from discovery to clinical trial and then marketing authorisation. Industry expertise You’ll have access to a rich training platform offered by the Gene Therapy Innovation and Manufacturing Centre (GTIMC). We work closely with GTIMC partners, including:

• Advanced Therapy Manufacturing Industry Consortium

• Cell and Gene Therapy Catapult

• Cobra and Advanced Therapies Apprenticeship Community